甲肿方是治疗良性非毒性甲状腺肿的有效方剂。
Jiazhongfang is an effective prescription in treating benign non-toxic goiter.
掌握非毒性甲状腺肿、毒性甲状腺肿的病变特点。
To master pathologic features of diffuse nontoxic goiter and diffuse toxic goiter.
方法分析16例毒性甲状腺肿合并甲状腺隐性癌病例的临床及病理资料。
Methods 16 cases of toxic goiter complicated by occult carcinoma were analysed.
利用放射性核素131i治疗弥漫性毒性甲状腺肿已经成为临床的主要方法之一。
The use of radionuclide 131i in treatment of diffuse toxic goiter has become one of the main clinical methods.
术后病理报告25例腺瘤，16例结节性甲状腺肿并囊性变，3例弥漫性毒性甲状腺肿。
Pathological findings showed 25 cases of thyroid adenoma, 16 cases of nodular goiter, and 3 cases of Graves disease.
结论：手术治疗毒性甲状腺肿是安全有效的，须行合理的术前准备及选择适当的手术方式。
Conclusion: surgical treatment is safe and effective for TMNG, and preoperative medical treatment and appropriate option of surgical procedure were required.
其他结节6个，包括弥漫性毒性甲状腺肿1个、灶性淋巴细胞性甲状腺炎3个、亚急性肉芽肿性甲状腺炎2个。
Other nodules were in 6 cases, including diffuse toxic goiter in 1 case, local lymphocytic thyroiditis in 3 cases, and subacute granulomatous thyroiditis in 2 cases.
目的：观察中药泻火养阴散治疗初发毒性弥漫性甲状腺肿(格雷夫斯病)的治疗效果。
Objective: to observe the therapeutic effect of Xiehuo Yangyin powder (XHYY) in treating the initial stage of toxic and diffuse goiter (Graves disease).
目的总结毒性结节性甲状腺肿的治疗体会。
Objective to summarize the experience of the surgical treatment of toxic multinodular goiter (TMNG).
在接受抗甲状腺药物(atd)治疗的突眼性甲状腺肿615例患者中，215例(34.9%)发生毒性反应。
Out of 615 patients with Graves' disease who accepted the treatment of antithyroid drugs (ATD), 215 (34.9%) developed toxic effects of the drugs.
方法对1990 ~ 2006年收治的66例毒性结节性甲状腺肿行手术治疗的临床资料进行回顾性分析。
Methods Clinical data of 66 patients hospitalized with TMNG from 1990 to 2006 were reviewed.
方法对1990 ~ 2006年收治的66例毒性结节性甲状腺肿行手术治疗的临床资料进行回顾性分析。
Methods Clinical data of 66 patients hospitalized with TMNG from 1990 to 2006 were reviewed.
应用推荐